Filter
471
Text search:
adverse
drug
event
Featured
Recommendations
65
New Publications
103
Language
Document type
No document type
255
Guidelines
86
Studies & Reports
66
Manuals
29
Strategic & Response Plan
15
Fact sheets
8
Training Material
6
Situation Updates
3
App
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
28
Western and Central Europe
23
Global
14
South Africa
13
Latin America and the Carribbean
11
Ethiopia
10
Eastern Europe
10
Nigeria
9
Uganda
9
Kenya
9
Africa
9
Ghana
8
Syria
5
Bangladesh
5
Philippines
4
Nepal
4
Tanzania
4
Rwanda
4
South–East Asia Region
4
Liberia
3
USA
3
Zimbabwe
3
Cambodia
3
Malawi
3
Namibia
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Sierra Leone
2
Lesotho
2
West and Central Africa
2
Asia
2
Tajikistan
2
Congo, Democratic Republic of
1
Cameroon
1
South Sudan
1
Iraq
1
Zambia
1
China
1
Mozambique
1
Argentina
1
Eswatini/ Swaziland
1
North Macedonia
1
Ukraine
1
Botswana
1
East and Southern Africa
1
Western Pacific Region
1
Bhutan
1
Timor Leste/ East Timor
1
Russia
1
Kyrgyzstan
1
Kazakhstan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
141
Clinical Guidelines
74
Public Health
27
Women & Child Health
25
Key Resources
15
Pharmacy & Technologies
12
Capacity Building
8
Toolboxes
TB
56
Mental Health
50
HIV
44
COVID-19
31
Pharmacy
23
AMR
17
Caregiver
16
NTDs
16
NCDs
10
Ebola & Marburg
9
Rapid Response
9
Planetary Health
9
Conflict
7
Specific Hazards
7
Malaria
6
Natural Hazards
5
Refugee
5
2.0 Rapid Response
5
Disability
4
Polio
4
Global Health Education
4
Cholera
2
Zika
1
Social Ethics
1
Introduction Pharmacovigilance (PV) systems to monitor drug and vaccine safety are often inadequate in sub-Saharan
Africa. In Malawi, a PV enhancement initiative was introduced to address major barriers to PV.
Objective The objective of this initi
...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica
...
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 37.
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Revised Edition
2nd edition. The Event-based Surveillance Framework is intended to be used by authorities and agencies responsible for surveillance and response. This framework serves as an outline to guide stakeholders interested in implementing
...
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Accessed: 07.11.2019